Cargando…

CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy

SIMPLE SUMMARY: In this study, we first reported the infiltration and prognostic value of CXCR6+TAMs in all stages of colon cancer patients and assessed predictive ability as a biomarker for different duration adjuvant chemotherapy regimens in the primary cohort and validation cohort Patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jiang, Lin, Songbin, Mao, Yihao, Xu, Yuqiu, Zhang, Zhiyuan, Wu, Qi, Chen, Yijiao, Wei, Ye, Feng, Qingyang, Xu, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562861/ https://www.ncbi.nlm.nih.gov/pubmed/36230570 http://dx.doi.org/10.3390/cancers14194646

Ejemplares similares

Analysis of tumor microenvironment‐related key mRNAs and construction of a prognosis signature in colon cancer
por: Zhang, Zhiyuan, et al.
Publicado: (2020)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study
por: Xu, Yuqiu, et al.
Publicado: (2021)

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
por: Mao, Yihao, et al.
Publicado: (2018)

No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and Prognosis
por: Chang, Jiang, et al.
Publicado: (2022)

Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer
por: Chen, Fangfang, et al.
Publicado: (2019)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

B cells in tumor metastasis: friend or foe?
por: Xu, Yuqiu, et al.
Publicado: (2023)

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study
por: Chang, Wenju, et al.
Publicado: (2023)

The immune phenotypes and different immune escape mechanisms in colorectal cancer
por: Mao, Yihao, et al.
Publicado: (2022)

The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
por: Collienne, Maike, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
por: Xu, Yijia, et al.
Publicado: (2022)

Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
por: Song, Ji Hyeong, et al.
Publicado: (2022)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer
por: Shen, Kaiyu, et al.
Publicado: (2023)

Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer
por: Yang, Jihua, et al.
Publicado: (2018)

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
por: Jeon, Hyeong-Joon, et al.
Publicado: (2011)

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
por: Joshi, Rohit
Publicado: (2013)

Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
por: Oki, Eiji, et al.
Publicado: (2021)

The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine
por: Sun, Jing, et al.
Publicado: (2021)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression
por: Xiao, Yong, et al.
Publicado: (2022)

Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer
por: Xu, Jianmin, et al.
Publicado: (2020)

Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
por: Zhao, Jingkun, et al.
Publicado: (2017)

Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020)

Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains
por: Silva, L.A., et al.
Publicado: (2012)

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
por: De Bruyn, Christine, et al.
Publicado: (2021)

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma
por: Zhu, Qiaoliang, et al.
Publicado: (2020)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML
por: Bao, Xiebing, et al.
Publicado: (2023)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
por: Nishioka, Yuri, et al.
Publicado: (2023)

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
por: Romain, Benoît, et al.
Publicado: (2014)

CXCR4-guided liposomes regulating hypoxic and immunosuppressive microenvironment for sorafenib-resistant tumor treatment
por: Wang, Yuehua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6ak7is3mfi1m8ijhad6496l7t